Parental Leave Does Not Negatively Impact Ophthalmologic Residents
TUESDAY, Oct. 4, 2022 (HealthDay News) — Among ophthalmologic residents, there are no differences across performance metrics between residents taking parental leave versus their peers not taking leave, according to a study published online Sept. 29 i…
Learn MoreMedicare Eligibility Linked to Improvements in Health Care Access
TUESDAY, Oct. 4, 2022 (HealthDay News) — Medicare eligibility and enrollment at age 65 years is associated with improvements in some measures of health care access and affordability, according to a study published online Oct. 4 in PLOS Medicine.Rahul…
Learn MoreAntidepressants in Pregnancy Do Not Affect Child Neurodevelopment
TUESDAY, Oct. 4, 2022 (HealthDay News) — Antidepressant use in pregnancy is not associated with an increased risk for neurodevelopmental disorders in children, according to a study published online Oct. 3 in JAMA Internal Medicine.Elizabeth A. Suarez…
Learn MoreSuicide Risk Up for Some Patients Diagnosed With Dementia
TUESDAY, Oct. 4, 2022 (HealthDay News) — Specific subgroups of patients diagnosed with dementia may have an increased risk for suicide, including those diagnosed before age 65 years, according to a study published online Oct. 3 in JAMA Neurology.Dana…
Learn MoreTopical Antibiotics Shorten Duration of Conjunctival Symptoms
TUESDAY, Oct. 4, 2022 (HealthDay News) — For children with acute infective conjunctivitis, topical antibiotics are associated with a shorter duration of conjunctival symptoms, according to a study published online Oct. 4 in JAMA Network Open.Minna Ho…
Learn MoreInfections Reported After Single Dose of Monkeypox Vaccine
TUESDAY, Oct. 4, 2022 (HealthDay News) — Most cases of monkeypox that occur after vaccination with the modified Vaccinia Ankara-Bavarian Nordic vaccine (MVA-BN) occur within 14 days of receipt of the first dose, according to a research letter publish…
Learn MorePirfenidone Promising for RA-Linked Interstitial Lung Disease
TUESDAY, Oct. 4, 2022 (HealthDay News) — Pirfenidone may slow the rate of decline of forced vital capacity (FVC) among patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD), according to a study published online Sept. 5 in …
Learn MoreApremilast May Offer Cardiometabolic Benefit in Psoriasis Patients
TUESDAY, Oct. 4, 2022 (HealthDay News) — For patients with moderate-to-severe psoriasis, apremilast appears to have a neutral association with aortic vascular inflammation, generally beneficial associations with certain cardiometabolic biomarkers, an…
Learn MoreUse of Living-Donor Liver Transplantation Low in U.S., U.K., Canada
TUESDAY, Oct. 4, 2022 (HealthDay News) — Utilization of living-donor liver transplantation (LDLT) is low in the United States, Canada, and the United Kingdom, but long-term survival is high, according to a study published online Sept. 25 in the Journ…
Learn MoreRituximab Studied as Add-On Therapy for New-Onset Myasthenia Gravis
TUESDAY, Oct. 4, 2022 (HealthDay News) — A single infusion of rituximab early after the onset of generalized myasthenia gravis improves outcomes at 16 weeks, according to a study published online Sept. 19 in JAMA Neurology.Fredrik Piehl, M.D., Ph.D.,…
Learn More